摘要 |
The invention discloses a new plypeptide- cyclin-dependent kinase-CDK411, the polynucleotide encoding said polypeptide, and a process for producing the polypeptide by recombiannt DNA technology. It also discloses methods of applying the polypeptide for the treatment of various diseases, such as malignacy, hemopathy, development disorder, HIV infection, immune disorders, and inflammation. This invention also discloses antagonist against said polypeptide and thereof therapy uses. In addition, it refers to the use of said polynucleotide encoding this new cyclin-dependent kinase-CDK411.
|